MADRID, June 7 (Reuters) - Spain's Grifols has agreed to buy U.S.-based Talecris Biotherapeutics , which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in ...
Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ...
MarketWatch: Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
The Globe and Mail: Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
Donors giving blood plasma at Grifols’ paid collection centres are not informed that some medicines made from their donations will be sold for profit overseas, according to testimony from a Canadian ...
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
MADRID (Reuters) - Spain's Grifols has agreed to buy U.S.-based Talecris Biotherapeutics , which makes plasma-based protein medicines, for $3.4 billion in a bold move to expand its business in ...
The Globe and Mail: Ontario approves Spanish pharmaceutical firm Grifols paying plasma donors despite ban
The Globe and Mail: Hamilton rebukes Canadian Blood Services, Grifols over paying for blood plasma donations
Hamilton, Ont., has rebuked Canadian Blood Services and Spanish pharmaceutical company Grifols over their plans to set up for-profit blood-plasma collection in the city, a practice that some health ...
Hamilton rebukes Canadian Blood Services, Grifols over paying for blood plasma donations